Literature DB >> 29728935

Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia.

C Lapucci1, E Capello2, N Romano3, F Guolo4, N Mavilio5, L Roccatagliata3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29728935     DOI： 10.1007/s10072-018-3435-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Myelopathy following intrathecal chemotherapy in adults: a single institution experience.

Authors:  David Cachia; Carlos Kamiya-Matsuoka; Chelsea C Pinnix; Linda Chi; Hagop M Kantarjian; Jorge E Cortes; Naval Daver; Karin Woodman
Journal:  J Neurooncol       Date:  2015-02-10       Impact factor: 4.130

2.  Methotrexate myelopathy with extensive transverse necrosis: report of an autopsy case.

Authors:  Masayuki Shintaku; Nao Toyooka; Takashi Koyama; Shunsuke Teraoka; Mitsuru Tsudo
Journal:  Neuropathology       Date:  2014-07-02       Impact factor: 1.906

3.  MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk.

Authors:  Kelsey Juster-Switlyk; A Gordon Smith; Tibor Kovacsovics; Deborah Stephens; Martha Glenn; Cheryl Ann Palmer; Edward P Quigley; Noah Kolb
Journal:  Neurology       Date:  2017-01-06       Impact factor: 9.910

4.  Transverse myelopathy following intrathecal administration of chemotherapy.

Authors:  H S Teh; S A W Fadilah; C F Leong
Journal:  Singapore Med J       Date:  2007-02       Impact factor: 1.858

Review 5.  Excessive spinal cord toxicity from intensive central nervous system-directed therapies.

Authors:  J Watterson; I Toogood; M Nieder; M Morse; S Frierdich; Y Lee; C L Moertel; J R Priest
Journal:  Cancer       Date:  1994-12-01       Impact factor: 6.860
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.